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Identifying critical parameters in the dynamics and control of microparasite
infection using a stochastic epidemiological model1
M. Nath2, J. A. Woolliams, and S. C. Bishop
Roslin Institute (Edinburgh), Roslin, Midlothian EH25 9PS, U.K.
ABSTRACT: A stochastic epidemic model is pre-
sented to study infection transmission dynamics, and
hence epidemic severity and disease incidence, in a
closed population. The aim was to understand the rela-
tive importance of various parameters that influence
the dynamics of potential epidemics, particularly when
the genetic mechanisms of resistance or tolerance to
infection are considered. Simulations explored the ef-
fect of varying the transmission coefficient, latent pe-
riod, recovery period, mortality rate, and the period of
loss of immunity on overall epidemic outcomes. The
critical parameters influencing the transmission of in-
fection, and hence disease incidence, were the transmis-
Key Words: Animal Health, Disease Resistance, Disease Transmission, Epidemiology, Genetics, Immunology
2004 American Society of Animal Science. All rights reserved. J. Anim. Sci. 2004. 82:384–396
Introduction
Animal health affects production economics, animal
welfare, and food safety. Previously, disease control has
been achieved by such strategies as chemotherapy, vac-
cination, sanitation, culling, and biosecurity. However,
these approaches are not always effective. Besides, an
increased and inappropriate use of chemicals or vac-
cines has often led to the evolution of resistant patho-
gens, with concerns expressed over the potential con-
tamination of animal products. Therefore, alternative
disease control measures are needed and an exploita-
tion of genetic variation among hosts in resistance to
infection may complement or sometimes replace ex-
isting strategies.
Genetic differences between animals in resistance to
infection have been documented for all major domestic
species and for many important diseases (Axford et al.,
2000; Bishop et al., 2002). Currently, there is a large
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sion coefficient, the latent period, and the recovery pe-
riod; the period of loss of immunity had only trivial
effects. Ideally, control strategies should decrease the
transmission coefficient and/or increase the latent pe-
riod and/or decrease the recovery period. By equating
measured traits with disease transmission parameters,
themodel described in this paper can be used to identify
which disease resistance genes or QTL will be truly
effective in helping to develop disease-resistant live-
stock that suffer fewer epidemics and side-effects of
infection. In particular, emphases should be placed on
finding genes that decrease the transmission of infec-
tion, increase the latent period, or decrease the recov-
ery period.
research effort worldwide attempting to exploit this ge-
netic variation by gene discovery. However, it is not
always obvious which genes or QTL will be most effec-
tive in controlling infection or disease and improving
health. For example, studies by Vallejo et al. (1998)
and Yonash et al. (1999) found 14 QTL associated with
resistance to Marek’s disease, for a total of nine traits
describing the proliferation of tumors, survival, and
viremia. A critical question for the implementation of
breeding strategies is which of these QTL would be
most effective in helping to control the disease.
This article addresses the traits or processes that are
critical in controlling the transmission of infection, and
hence improving flock or herd health, for microparasitic
(e.g., bacterial or viral) infections. A stochastic epidemic
modeling approach to describing microparasitic infec-
tions was demonstrated by MacKenzie and Bishop
(2001), and, in the present article, the model is adapted
to assess the relative importance of various genetic reg-
ulation strategies in controlling the transmission of in-
fection, and hence the incidence of disease.
Material and Methods
Overview of Methodology
This article will explore the properties of epidemics in
closed populations caused by microparasitic infections
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and will determine the processes or parameters that
are critical in determining the severity of the epidemics.
By relating these processes or parameters to measur-
able traits, we can then determine the types of QTL or
genes that will have the greatest impact in disease
control and improving herd health. To achieve this, our
approach will be as follows. Wewill develop a stochastic
model describing the transmission of infection and the
severity of subsequent epidemics and apply it within
a simple defined population. An important livestock
diseasewill be identified for which parameter estimates
are available from published literature, to give bench-
mark results. We will then explore the reasonable pa-
rameter space, as described below, for each parameter,
simulating the consequences of altering each parameter
in turn.
Population Structure
We considered a medium-sized population of inten-
sively housed animals, such as pigs. The population
comprised 1,000 individuals of the same age and physio-
logical status. For simplicity, the population was con-
sidered to be completely homogenous, with equal mix-
ing among individuals. The population was assumed to
be closed, with no new introductions of animals during
the epidemic period. There was no disease-independent
mortality in the population. It was also assumed that,
once an epidemic started, there was no external inter-
vention (such as medication, vaccination, isolation) to
check the progress of the epidemic and that the epi-
demic took its own course.
Infection Process and Parameter Definition
The transmission of infection during microparasitic
epidemicsmay be described by so-called compartmental
models (Anderson and May, 1992), in which animals
move from one state to another, defined according to the
events that follow as a result of infection. The phases of
infection in the host can be broadly defined as follows.
First, a susceptible individual gets infected from an
infected individual. The transmission coefficient (β) de-
notes the rate at which infected individuals transmit
infection to susceptible animals, and is the expected
number of new infections per infectious animal per sus-
ceptible animal per day. In the context of disease genet-
ics, the parameter β depends upon the infectivity geno-
types of infected animals and the susceptibility geno-
types of susceptible animals. Therefore, for a constant
infectivity, β is proportional to the susceptibility geno-
types of animals. Conversely, for a constant susceptibil-
ity, β is proportional to the infectivity genotypes of the
infected animals.
After infection, the latent period ensues, which is
the period during which the individual is infected but
noninfectious, and is not yet capable of transmitting
the infection because the abundance of the infectious
agent is low. The parameter σ is the inverse of the
expected latent period.
The next phase is the infectious period when the
abundance of pathogens is high and the individual is
capable of infecting other susceptible individuals. After
the infectious phase, host recovery may occur when the
abundance of pathogens decreases to a low level or zero
and antibody titers rise to a high level to prevent any
further infection for a definite period. The recovery rate
(γ) is the reciprocal of the infectious period and is the
expected number of recoveries per infected animal per
day. Infected individuals also may die as a result of
infection. The mortality rate (ε) implies the disease-
dependent mortality, which is the expected proportion
of individuals dying per day among the infected indi-
viduals.
Finally, the immunity in the recovered individuals
may not be life-long and may persist only for a period
of time, after which they become susceptible again. The
rate of loss of immunity (ω) is represented by the recip-
rocal of the expected period between the time of recov-
ery and the time when recovered individuals again be-
come susceptible. Here it is assumed that ω > 0 for the
present infection, so that immunity is not life-long. We
will refer to this period as the loss-of-immunity period.
Epidemic Model
The stochastic epidemicmodel used in this paper was
outlined by MacKenzie and Bishop (2001). In brief, a
stochastic epidemic model simulates the epidemic pro-
cess as a series of random events in time, with the
probability of specific events defined by the parameters
of the model. The possible event types for this model
are as follows: a susceptible animal becomes latently
infected, a latently infected animals becomes infectious,
an infected animal recovers or dies as a result of infec-
tion, and an animal that has recovered loses immunity
and becomes immunologically susceptible again.
In addition to event type, the model requires simula-
tion of the inter-event time. For a population with I
infected animals, S susceptible animals, L animals in
the latent class, and R recovered animals; the inter-
event time in an epidemic has a mean
1/(βcSI + σL + γI + εI + ωR) [1]
where c is the contact rate between animals (assumed
to be 1 in this paper), and other parameters are as
defined above. The inter-event time may then be drawn
from an exponential distribution as ln(r) × (mean inter-
event time), where r is a random number in [0, 1].
The next event type is determined by calculating the
probability of a specific event in relation to all possible
events. Thus, let Eq. [1] be RATE, then the probabilities
that the next event is (i) the infection of an animal
moving the newly infected animal to the latent class is
βcSI × RATE, (ii) the movement of a latent animal to
the infectious class is σL × RATE, (iii) the recovery of
an infected animal is γI × RATE, (iv) the death of an
infected animal is εI × RATE, and (v) the loss of immu-
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nity of a recovered animal is ωR × RATE. Thus, the
precise event can be determined by sampling from a
random uniform distribution.
Implementing the Model and Capturing the Output
The model is implemented by introducing a single
infected individual (the index case) into the farm. The
inter-event time is calculated, the type of the first event
is determined, and the epidemic commences. The epi-
demic continues until no infected animals remain at the
end of the epidemic, or some predetermined criterion in
terms of the severity or length of the epidemic has been
exceeded. Outputs were captured and summary statis-
tics derived as follows.
Probability of Epidemic. The probability that an epi-
demic will occur, given the presence of an infected indi-
vidual, can be determined by the number of simulations
that result in an epidemic. If the infected individual
that was introduced in the population at the start of
the epidemic recovers or dies without any secondary
infections, then it is considered to be no epidemic. Oth-
erwise, epidemicsmay be split into those that are major
and those that are minor epidemics. Minor epidemics
are those that die out without intervention (Bishop and
MacKenzie, 2003). To distinguish unambiguously be-
tween major and minor epidemics, it may be necessary
to let the simulations run for a very long time, and, for
practical purposes, thresholdsmay be set to distinguish
them. In these simulations, if more than 10% of individ-
uals in the population became infected and the epidemic
continued for more than 6 mo without intervention, the
epidemic was deemed as being major. Otherwise, the
epidemic was considered as minor. The choice of 10%
of animals infected as the threshold was made on the
grounds that epidemics that died out quickly generally
resulted in fewer than 10% of the population becoming
infected. However, our thresholds for major and minor
epidemics are specific to the parameter space investi-
gated and may not be appropriate for diseases with
very high R0 values (see below) or mortality rates.
Basic Reproductive Ratio.The basic reproductive ratio
(R0), is a dimensionless parameter that encapsulates
the biological details of different transmission mecha-
nisms. For microparasites, R0 is the expected number
of secondary infections produced by the introduction of
an infected individual, during the course of its infec-
tious period, into an otherwise completely susceptible
population (Diekmann et al., 1990). In general, the
probability of no epidemic (p) can be expressed as 1/
(R0 + 1) (Bishop and MacKenzie, 2003). Hence, R0 was
estimated as (1/p) − 1.0.
Epidemic Severity. Epidemic severity was defined in
terms of the maximum proportion of animals infected
during the epidemic (ymax) and the time of occurrence of
ymax. The estimate of ymax was averaged for replications
when a major epidemic occurred. Since the condition
for determining a major epidemic was more than 10%
of animals infected and a duration of 6 mo, simulations
were stopped when they reached these thresholds.
Therefore, summary parameters, such as the total pro-
portion of animals that were infected and the duration
of major epidemics, were not estimated.
Disease Case Study and Parameter Space Investigated
As a case study, we have considered transmissible
gastroenteritis (TGE), a highly contagious enteric viral
disease of swine. This disease is characterized by vom-
iting, severe diarrhea, and high mortality in pigs of less
than 2 wk of age. Mortality is low in pigs over 5 wk of
age, but considerable morbidity may occur as a result
of infection. No specific treatment or effective vaccines
are available for TGE. Estimates of parameters describ-
ing TGE have been published for growing pigs (Hone,
1994): the transmission coefficient (0.0007), latent pe-
riod (2 d), recovery period (20 d), mortality rate (0.02),
and days before loss of immunity (180 d).
In addition to the case study, the reasonable parame-
ter space was investigated for each parameter, using
the TGE parameters as benchmark values. The reason-
able parameter space was defined by biological limits
to each parameter as well as simulation outcomes. In
this case, we wished to avoid outcomes in which R0
exceeded 10, as diseases that are this infectious are
probably best dealt with by nongenetic means. The aim
was to examine the changes in epidemic pattern by
introducing variation in one parameter, keeping other
parameters constant. The specific parameter combina-
tions were as follows: transmission coefficients (β),
where it takes the value of 0.00001, 0.00005, 0.0001,
0.0005, 0.0007, or 0.001; six latent periods (1, 2, 7, 15,
30, and 180 d); six recovery periods (1, 2, 5, 10, 20, and
30 d); six mortality rates (0.00, 0.02, 0.05, 0.10, 0.20,
and 0.30); and six values for the loss-of-immunity period
(7, 15, 30, 60, 120, and 180 d). A total of 5,000 replicates
were run for each combination of parameters.
Results
Case Study
The probabilities of no epidemic, a minor epidemic,
and a major epidemic of TGE—obtained from 5,000
replicates—were 0.17, 0.01, and 0.82, respectively. A
summary of other parameters is presented in Table 1.
The high probability of a major epidemic means that,
without any intervention, there is high chance that
TGE will spread in more than 10% of animals in the
population and the epidemic will last for more than 6
mo. The definition of a major epidemic that was used
overestimated the incidence of “true” major epidemics,
which is expected to be (R0 − 1)/(R0 + 1) (Bishop and
Mackenzie, 2003). However, in most practical situa-
tions, the definition of a major epidemic as one in which
more than 10% of individuals become infected and the
epidemic duration is of more than 6 mo seems conser-
vative.
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Table 1. Probability of no/minor/major epidemic, basic reproductive ratio (R0), maximum
proportion of infected animals (ymax), and time of ymax (ymaxTime) and their corresponding
standard deviations for different transmission coefficients (β), with other parameters held
constant, based on 5,000 replicatesa
Probability of epidemic Estimates
β × (10−5),
S−1I−1d−1 b No epidemic Minor epidemic Major epidemic R0 ymax ymaxTime, d
1c 0.893 0.107 0.000 0.12 0.000 —
(0.004)d (0.004) (0.000) (0.01) (0.000) (—)
5ef 0.632 0.368 0.0002 0.58 0.021 125.9
(0.006) (0.006) (0.0003) (0.02) (0.002) (58.21)
10f 0.473 0.276 0.250 1.11 0.056 155.4
(0.006) (0.006) (0.008) (0.03) (0.001) (0.89)
50 0.197 0.026 0.777 4.08 0.512 33.7
(0.002) (0.001) (0.003) (0.06) (0.0004) (0.02)
70g 0.169 0.012 0.819 4.92 0.578 26.4
(0.002) (0.003) (0.002) (0.06) (0.0001) (0.01)
100 0.147 0.011 0.842 5.80 0.629 20.8
(0.002) (0.001) (0.002) (0.10) (0.0004) (0.01)
aOther parameters in the model are kept constant (latent period = 2 d; recovery period = 20 d; mortality
rate = 2%/d; and loss-of-immunity period = 180 d).
bS indicates the number of susceptible individuals, and I indicates the number of infected individuals.
cNo major epidemic was observed in 5,000 replicates and hence ymax is zero and no ymaxTime was recorded.
dThe standard deviations were calculated from parameter estimates obtained from 5,000 potential epidem-
ics, further replicated 20 times to obtain a sample of estimates, and are shown in parentheses under each
estimate.
eAmong 20 estimates of 5,000 replicates each, 2 estimates based on 5 cases and 11 estimates based on 9
cases of major epidemic. The estimates of standard deviations for ymax and ymaxTime reflect these small
sampling sizes.
fThe failure of a given row of probabilities to sum to 1.0 is attributable to rounding error.
gBoldface type values indicate the epidemic properties for transmissible gastroenteritis with benchmark
parameters values.
Effects of Altering the Transmission Coefficient
The epidemic properties for TGE for benchmark pa-
rameters except for the transmission coefficient (β),
which is varied, are presented in Table 1. As β de-
creases, the probability of a major epidemic reduces
considerably, and with β less than 0.00005 there is
practically no incidence of major epidemics. The esti-
mates of R0 also correspond proportionally to values of
β. Because the parameter β varies proportionally with
the host genotype for susceptibility, everything else
held constant, it can be concluded that β is of immense
importance for the genetic control of disease resistance.
It signifies whether a susceptible individual exposed to
infection will readily get the infection or whether it will
resist the establishment of the infectious organisms
inside its body. Further results indicating the effect of
β with changes in other parameters are presented in
later sections.
Effects of Altering the Latent Period
As a general summary, the estimated R0 increases
as the latent period decreases (Figure 1a). This indi-
cates that the quicker the infected individual starts
shedding the infection, the greater the chances of other
animals becoming infected. Additionally, R0 is more
sensitive to changes in the latent period as β increases.
For example, when β = 0.00005, the R0 value reduces
from 0.58 to 0.42 when the latent period increases from
2 to 7 d. However for the similar change in latent period,
the R0 value decreases from 5.80 to 3.74 when β = 0.001.
The estimate of ymax also increases with a decrease
in the latent period, for fixed values of other parameters
(Figure 2a). For β = 0.001, the maximum proportion of
individuals affected is almost 69% when the latent pe-
riod is 1 d. There is declining trend of the incidence of
major epidemics when the latent period is increased.
The time of ymax is also affected by the latent period
(Figure 3a). It is observed that with an increase in
the latent period there is also an increase in time of
occurrence of ymax. Therefore, an increase in the latent
period not only reduces the maximum proportion of
individuals infected, but simultaneously it delays the
time when ymax will occur.
The effect of latent period on the dynamics of epi-
demic is evident from Table 2. Although the changes
in the epidemic pattern are not appreciable when β
is low, with higher values of β the changes are more
prominent. If the latent period is very long, there is a
low chance of a major epidemic even with a high value
of β. For example, with β values ranging from 0.0005
to 0.001, the estimates of R0 are less than one when
the latent period is as long as 180 d. Hence, infective
organisms with long latent periods will seldom cause
major epidemics in a population as modeled in this
paper, even if they have high transmission coefficients.
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Figure 1. Comparison of estimates of the basic reproductive ratio (R0) vs. different epidemiological parameters: (a)
latent period, (b) recovery period, (c) mortality rate, and (d) loss-of-immunity period, for transmission coefficients (β
× 10−5) of 1 (), 5 (), 10 (), 50 (◆), 70 (▲), and 100 ().
Effects of Altering the Recovery Period
For fixed values of β, the estimated R0 increases as
the recovery period increases (Figure 1b). The variation
in estimates of R0 over a range of recovery periods is
very low when β is low; however, the variation in R0 is
much greater for high values of β. For example, for a
change of recovery period from 1 to 30 d, the change in
R0 is 0.31 when β = 0.00005, whereas the equivalent
change in R0 is 3.17 when β = 0.001. Hence, variation
in the recovery period does not greatly influence R0 if
β is low.With high β values, changes in R0 with changes
in recovery period are more appreciable.
From Figure 2b, it can be observed that changes in
the recovery period also influence themaximumpropor-
tion of infected animals in the population (ymax). In the
range of β from 0.0005 to 0.001, increasing the recovery
period from 5 to 20 d increases the ymax value by twofold
or more. However, the time of occurrence of ymax is less
influenced by the recovery period for moderate to high
β values (Figure 3b). That means with a long recovery
period the rate of spread of infection is much faster
and more individuals are infected in an epidemic of a
similar duration.
For a fixed value of β, the probability of no epidemic
increases and the probability of major epidemics de-
creases with a decrease in the recovery period (Table
3). For intermediate to high transmission coefficients,
the probability of minor epidemics is maximized for an
intermediate recovery period. The probability of amajor
epidemic is almost nil for β values of 0.00005 or less,
and it does not exceed 2% even if an animal takes as
long as 30 d to recover from infection. However, for an
infection with a moderate to high β, the recovery period
plays an important part in removing the infection from
the population. With a high β value of 0.001, the proba-
bility of a major epidemic reduces from 73 to 5% when
the recovery period decreases from 10 to 5 d. Therefore,
with increasing β values, there is a definite advantage
in decreasing the recovery period.
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Figure 2. Comparison of estimates of maximum proportion of infected animals (ymax) vs. different epidemiological
parameters: (a) latent period, (b) recovery period, (c) mortality rate, and (d) loss-of-immunity period, for transmission
coefficients (β × 10−5) of 1 (), 5 (), 10 (), 50 (◆), 70 (▲), and 100 ().
Effects of Altering the Mortality Rate
The estimates of R0 decrease with an increase in mor-
tality rate (Figure 1c). This happens because a high
mortality rate leads to the elimination of the infected
individuals from the population, thus preventing fur-
ther spread of the infection. Hence, the concept of mor-
tality can be considered equivalent to the concept of
culling. Paradoxically, diseases with a mortality rate
of more than 20% do not cause major epidemics as
defined in this paper, even with high β values (Table
4), simply because the criteria of 6-mo duration and 10%
infected are not reached. This phenomenon is similarly
reflected in estimates of ymax.With a decrease inmortal-
ity rate, ymax increases in the range of intermediate to
high values of β, although the time of ymax remains
almost the same in this range (Figure 2c and 3c). The
apparent inconsistency of 72 d as the time of ymax for
β = 0.0005 and ε = 0.30 may be attributable to sampling
variation since only 5 cases out of 5,000 replications
actually showed a major epidemic for this parameter
combination (Table 4).
The results give some insights into the disease dy-
namics and in turn may help in optimum disease man-
agement. For example, for diseases with low to almost
no mortality, it is quite possible that the disease will
become endemic in the population if the β value is low
to moderate. In the case of diseases with high β values
(β = 0.001) and low mortality (ε = 0.02), it is always
advisable that the infected individuals are identified
and removed from the population as soon as possible
because the chance of the individual itself recovering
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Figure 3. Comparison of estimates of time of occurrence of ymax vs. different epidemiological parameters: (a) latent
period, (b) recovery period, (c) mortality rate, and (d) loss-of-immunity period, for transmission coefficients (β ×
10−5) 5 (), 10 (), 50 (◆), 70 (▲), and 100 (). In all graphs, the absence of time of occurrence of ymax for a combination
of parameter values indicates that no major epidemic was observed for that combination of parameters.
without infecting others (approximately 15%) is much
lower than the probability that it will infect others and
subsequently lead to more severe epidemics. If it is
maintained in the herd, there is approximately an 84%
possibility that it will infect more than 10% individuals
in the population and the epidemic will last for more
than 6 mo.
Effects of Altering the Loss-of-Immunity Period
With other parameters fixed, changes in the loss-of-
immunity period do not make any appreciable changes
in the epidemic pattern (Table 5), under the circum-
stances modeled in this paper. The estimates of R0 re-
main almost the same even with a wide range in the
loss-of-immunity period (from 7 to 180 d) within a given
β value (Figure 1d). There is also little change in the
estimates of ymax and the time of ymaxwhen other param-
eters are constant (Figure 2d and 3d). Therefore, the
loss-of-immunity period appears to be the least im-
portant parameter of those investigated, since it has
little influence on disease dynamics in the short term.
Discussion
Biological Context
Discoveries of various genes or quantitative trait loci
(QTL) associated with disease resistance clearly indi-
cate the possibilities of developing animal strains that
have enhanced genetic resistance to various diseases.
However, allelic variation at different genes may influ-
ence the disease dynamics in different ways, and, there-
fore, the main objective of this paper was to understand
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Table 2. Probability of no/minor/major epidemic for dif-
ferent transmission coefficients (β) and latent period
(1/σ) keeping other parameters constanta
Probability of epidemic
No Minor Major
1/σ, d epidemic epidemic epidemic
β = 1 × 10−5
1 0.89 0.11 0.00
2 0.89 0.11 0.00
7 0.92 0.08 0.00
15 0.94 0.06 0.00
30 0.96 0.04 0.00
180 0.99 0.01 0.00
β = 5 × 10−5
1 0.61 0.39 0.00
2 0.63 0.37 0.00b
7 0.71 0.29 0.00
15 0.77 0.23 0.00
30 0.84 0.16 0.00
180 0.95 0.05 0.00
β = 10 × 10−5
1c 0.46 0.28 0.27
2 0.47 0.28 0.25
7 0.57 0.25 0.18
15 0.66 0.23 0.11
30 0.75 0.21 0.04
180 0.92 0.08 0.00
β = 50 × 10−5
1 0.18 0.03 0.79
2c 0.20 0.03 0.78
7 0.30 0.04 0.66
15c 0.39 0.06 0.56
30c 0.48 0.10 0.43
180 0.74 0.17 0.09
β = 70 × 10−5
1 0.13 0.01 0.86
2 0.17 0.01 0.82
7 0.26 0.03 0.71
15 0.34 0.05 0.61
30c 0.44 0.07 0.50
180 0.69 0.16 0.15
β = 100 × 10−5
1 0.12 0.01 0.87
2 0.15 0.01 0.84
7 0.21 0.02 0.77
15c 0.30 0.03 0.66
30 0.37 0.05 0.58
180c 0.64 0.13 0.22
aOther parameters in the model are kept constant (recovery pe-
riod = 20 d; mortality rate = 2%/d; loss-of-immunity period = 180 d).
bOne case among 5,000 replicates.
cThe failure of a given row of probabilities to sum to 1.0 is attribut-
able to rounding error.
the critical parameters influencing the transmission of
infection and thus identify the potential significance of
different QTL or candidate genes in terms of alleviating
disease. The compartmental microparasitic epidemio-
logical model that we have used is governed by the
transmission coefficient (β) and such parameters as the
latent period (1/σ), recovery period (1/γ), disease-depen-
dent mortality rate (ε), and loss-of-immunity period (1/
ω). The challenge remains to relate these parameters
Table 3. Probability of no/minor/major epidemic for dif-
ferent transmission coefficients (β) and recovery period
(1/γ) keeping other parameters constanta
Probability of epidemic
No Minor Major
1/γ, d epidemic epidemic epidemic
β = 1 × 10−5
1 1.00 0.00c 0.00
2 0.99 0.01 0.00
5 0.97 0.03 0.00
10 0.94 0.06 0.00
20 0.89 0.11 0.00
30 0.86 0.14 0.00
β = 5 × 10−5
1 0.98 0.02 0.00
2 0.96 0.04 0.00
5 0.87 0.13 0.00
10 0.76 0.24 0.00
20 0.63 0.37 0.00b
30 0.56 0.42 0.02
β = 10 × 10−5
1 0.97 0.03 0.00
2 0.92 0.08 0.00
5 0.78 0.22 0.00
10 0.62 0.38 0.00c
20 0.47 0.28 0.25
30 0.41 0.17 0.42
β = 50 × 10−5
1 0.88 0.12 0.00
2 0.74 0.26 0.00
5 0.48 0.51 0.01
10 0.32 0.38 0.30
20e 0.20 0.03 0.78
30 0.16 0.01 0.83
β = 70 × 10−5
1 0.85 0.15 0.00
2 0.68 0.32 0.00
5 0.41 0.57 0.02
10 0.26 0.21 0.53
20 0.17 0.01 0.82
30 0.14 0.01 0.85
β = 100 × 10−5
1 0.79 0.21 0.00
2 0.62 0.38 0.00
5 0.35 0.60 0.05
10 0.22 0.05 0.73
20 0.15 0.01 0.84
30 0.11 0.00d 0.89
aOther parameters in the model are kept constant (latent period =
2 d; mortality rate = 2%/d; loss-of-immunity period = 180 d).
bOne case in 5,000 replicates.
cFifteen cases in 5,000 replicates.
dTwenty cases in 5,000 replicates.
eThe failure of a given row of probabilities to sum to 1.0 is attribut-
able to rounding error.
to measured traits on the animal. Achieving this and
then applying the model to specific diseases of interest
will lead to practical suggestions in terms of developing
strategies for choosing QTL or candidate genes for that
specific disease or similar diseases.
The parameter β depends on the infectivity of infected
animals, on the susceptibility to infection of uninfected
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Table 4. Probability of no/minor/major epidemic for dif-
ferent transmission coefficients (β) and mortality rate (ε)
keeping other parameters constanta
Probability of epidemic
No Minor Major
ε epidemic epidemic epidemic
β = 1 × 10−5
0.00 0.86 0.14 0.00
0.02 0.89 0.11 0.00
0.05 0.93 0.07 0.00
0.10 0.95 0.05 0.00
0.20 0.98 0.02 0.00
0.30 0.98 0.02 0.00
β = 5 × 10−5
0.00 0.53 0.43 0.04
0.02 0.63 0.37 0.00b
0.05 0.72 0.28 0.00
0.10 0.81 0.19 0.00
0.20 0.89 0.11 0.00
0.30 0.93 0.07 0.00
β = 10 × 10−5
0.00 0.39 0.16 0.45
0.02 0.47 0.28 0.25
0.05 0.57 0.40 0.03
0.10 0.69 0.31 0.00
0.20 0.81 0.19 0.00
0.30 0.87 0.13 0.00
β = 50 × 10−5
0.00 0.16 0.01 0.83
0.02f 0.20 0.03 0.78
0.05 0.27 0.60 0.13
0.10 0.36 0.64 0.00c
0.20 0.53 0.47 0.00
0.30 0.63 0.37 0.00c
β = 70 × 10−5
0.00 0.13 0.01 0.86
0.02 0.17 0.01 0.82
0.05f 0.23 0.48 0.30
0.10f 0.32 0.69 0.00
0.20 0.45 0.55 0.00
0.30f 0.55 0.46 0.00
β = 100 × 10−5
0.00f 0.08 0.00e 0.91
0.02 0.15 0.01 0.84
0.05 0.20 0.25 0.55
0.10 0.27 0.73 0.00d
0.20 0.39 0.61 0.00
0.30 0.50 0.50 0.00
aOther parameters in the model are kept constant (latent period =
2 d; recovery period = 20 d; loss-of-immunity period = 180 d).
bOne case in 5,000 replicates.
cFive cases in 5,000 replicates.
dTen cases in 5,000 replicates.
eTwenty cases in 5,000 replicates.
fThe failure of a given row of probabilities to sum to 1.0 is attribut-
able to rounding error.
animals, and in some cases on the proliferation of infec-
tion within the infected animals. Susceptibility may be
related to both immune andnonimmune response genes
that preclude infection or limit infection to the target
organ. For example, some pigs are genetically resistant
to infection with K88 (F4)-positive enterotoxigenic
Escherichia coli strains because they lack the gene for
Table 5. Probability of no/minor/major epidemic for dif-
ferent transmission coefficients (β) and loss of immunity
(1/ω) keeping other parameters constanta
Probability of epidemic
No Minor Major
1/ω, d epidemic epidemic epidemic
β = 1 × 10−5
7 0.89 0.11 0.00
15 0.89 0.11 0.00
30 0.89 0.11 0.00
60 0.89 0.11 0.00
120 0.89 0.11 0.00
180 0.89 0.11 0.00
β = 5 × 10−5
7 0.64 0.36 0.00
15 0.63 0.37 0.00b
30 0.62 0.38 0.00b
60 0.63 0.37 0.00b
120 0.63 0.37 0.00b
180 0.63 0.37 0.00
β = 10 × 10−5
7 0.48 0.26 0.26
15 0.48 0.26 0.26
30 0.49 0.26 0.25
60d 0.48 0.28 0.25
120d 0.48 0.27 0.26
180 0.47 0.28 0.25
β = 50 × 10−5
7 0.20 0.02 0.78
15 0.20 0.02 0.78
30 0.20 0.03 0.77
60 0.20 0.02 0.78
120 0.19 0.02 0.79
180d 0.20 0.03 0.78
β = 70 × 10−5
7 0.19 0.02 0.79
15d 0.17 0.02 0.82
30d 0.18 0.02 0.81
60d 0.17 0.02 0.82
120 0.17 0.02 0.81
180 0.17 0.01 0.82
β = 100 × 10−5
7 0.15 0.01 0.84
15 0.16 0.01 0.83
30 0.14 0.01 0.85
60d 0.15 0.00c 0.84
120 0.13 0.01 0.86
180 0.15 0.01 0.84
aOther parameters in the model are kept constant (latent period =
2 d; recovery period = 20 d; mortality rate = 2%/d).
bFive cases in 5,000 replicates.
cTwenty-five cases in 5,000 replicates.
dThe failure of a given row of probabilities to sum to 1.0 is attribut-
able to rounding error.
the intestinal receptor for the K88 adhesin (Francis et
al., 1998; Edfors-Lilja and Wallgren, 2000). Similarly,
two alpha (1,2) fucosyltransferase genes (FUT1, FUT2)
on porcine chromosome 6q11 have been identified and
are closely linked to E. coli F18 receptor (ECF18R) loci
(Meijerink et al., 1997). The absence of particular recep-
tors in the host prevents the pathogens from getting to
their target niche and thus helps in preventing estab-
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lishment of the pathogens. An example of limiting the
proliferation of microorganisms within the host system
is the natural resistance associatedmacrophage protein
1 (Nramp1; now renamed SLC11A1, for Solute carrier
family 11, member 1), an important candidate gene in
disease genetics studies. It is associated with enhanced
intracellular killing of bacteria by macrophages (Black-
well, 1996). It has been suggested that genetic differ-
ences in resistance to visceral infection by Salmonella
enteritidis in chickens are at least partly due to genetic
polymorphisms in theNramp1 region (Girard-Santosu-
osso et al., 2002). Genetic variation in β may also be
due to genetic variation in infectivity and this has been
clearly documented for nematode resistance in sheep,
a macroparasitic infection. For example, genetic varia-
tion has been demonstrated for the total number of eggs
shed per host per day and also the per capita fecundity
of the parasites resident in the gut (Stear et al., 1997).
As the pathogen gains entry inside the susceptible
host, it tries to escape from host immunity andmultiply
itself. During the latent period (1/σ), the number of
infectious agents is low and the host is infected but
incapable of transmitting the infection. Latency-related
genes in microorganisms have been reported in the lit-
erature and although this is not related to host geno-
type, their impacts may still be used to illustrate the
importance of the latent period. Several studies suggest
that latency-related gene products play an important
role in the latency or pathogenesis of BHV-1 (Jiang et
al., 1998; Ciacci-Zannela et al., 1999; Inman et al.,
2001).
When the pathogen enters into the host, the recogni-
tion, activation, and effector phases occur sequentially
in the host immune system. Host genetics plays an
important role in changing the recovery period (1/γ)
through various immune-associated genes. For exam-
ple, when foreign peptide (antigen) enters into the body,
the primary immunological function of major histocom-
patibility complex molecules is to bind and present
those antigenic peptides on the surfaces of cells for
recognition by antigen-specific T cell receptors of lym-
phocytes, which eventually leads to triggering of im-
mune response and destruction of pathogens. The asso-
ciations of major histocompatibility complex alleles in
various viral, bacterial, and macroparasite diseases in
chickens, cattle, pigs and horses are well documented
(Rothschild et al., 2000). The parameter recovery period
in our epidemic model would depend in part on how
quickly the effector phase can successfully remove the
pathogens. Therefore, selection for genes that decrease
recovery period would be advantageous because they
would elicit an early immune response to eliminate the
pathogens or to inhibit further multiplication of
pathogens.
The mortality rate (ε) is not directly related with
genetic control of the transmission of infection, as a
desirable decrease in disease-dependent mortality po-
tentially worsens epidemics, in terms of the number of
animals infected. Rather, it may be considered equiva-
lent to disease-dependent culling. The culling of in-
fected animals removes the infected individuals from
the population and reduces the further spread of the
infection to other susceptible animals. The control of
disease by immediate culling may be noted from the
example of the foot and mouth disease epidemic in
Great Britain. However, for welfare and economic rea-
sons, increased disease-dependent culling cannot be
considered as a selection objective. Clearly, decreased
disease-dependentmortality is desirable from both wel-
fare and economic perspectives, but it does not give the
insurance of decreasing the likelihood of future epidem-
ics in the herd nor does it decrease epidemic severity
in terms of the number of animals infected.
Finally, once exposed to foreign antigens, the immune
system provides protection to animals due to induction
of specific immunity that protects against future infec-
tion, which is also controlled by the host genetic system.
This is represented by the loss-of-immunity period
(1/ω) parameter in our model.
Interpretation of Results
Various stochastic epidemic models describing the
dynamics of infectious diseases in animals are available
(Bouma et al., 1995; Innocent et al., 1997; Stark et al.,
2000). Most of these studies address issues related with
population size, management practices, farm structure,
movement of animals, and the like. Some of these mod-
els are also very simple in their structure, which may
not be realistic for actual scenarios. Therefore, these
models may not be directly applicable to the decision
making process for genetic selection and the utilization
of information on QTL or candidate genes. MacKenzie
and Bishop (2001) demonstrated the use of genetic epi-
demiological models to quantify the impact of selection
for resistance to infectious diseases in livestock popula-
tions. However, they only considered the effect of alter-
ing β in the context of the infection dynamics.
The model presented in this article allows simultane-
ous investigation of the effects of altering several pa-
rameters. In many circumstances, as described above,
these parameters can be related to specific traits and
QTL for specific diseases. Of the parameters investi-
gated, the transmission rate β appears to be critical in
determining the disease dynamics. For low β values,
the effects of variation in other parameters, such as
σ, γ, ε, and ω, on infection dynamics are small. The
probability of a major epidemic is very low in diseases
with low transmission coefficients and therefore should
not generally be of prime concern, particularly for
small- or medium-sized herds as demonstrated in the
present model. Hence, if a disease is characterized by
β as 0.00005 or less, then it can safely be said that there
is no imminent danger of a major epidemic due to the
particular disease even if it has very short latent period,
short loss-of-immunity period, low disease-dependent
culling, or a long recovery period. In other words, we
should place particular importance on QTL or candi-
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date genes that can reduce the value of β considerably.
This is also justified when viewed with respect to other
epidemiological parameters, such as R0 and ymax. If
there is no change in values of σ, γ, ε, and ω, then
reducing β always has beneficial effects and would re-
sult in a reduction in the number of new infectious
cases and in the maximum proportion of infected indi-
viduals in the population.
However, it can be noted that the changes in β over
the defined parameter space do not always show uni-
form changes in major epidemic probabilities. Particu-
larly, for the population structure modeled, the crucial
range for β values seems to be from 0.00005 to 0.0005.
For example, a twofold increase of β from 0.00005 to
0.00010 increases the probability of a major epidemic
from 0.0002 to 0.25. On the other hand, for a similar
twofold increase of β from 0.0005 to 0.0010, the major
epidemic probability increases from 0.78 to 0.84. There-
fore, the epidemic outcomes are very sensitive to
changes in β in the range of 0.00005 to 0.0005.
If the disease is characterized by medium to high β
values, or if the available QTL information cannot re-
duce the value of β to a desired level in the population,
thenwe should givemore attention to other parameters
that we have described in the model, such as the latent
period, recovery period, and disease-dependent mortal-
ity rate.
It has been observed that with a constant β value
and the assumption of an infectious challenge on only
one occasion, the loss-of-immunity period (1/ω) is the
least important parameter affecting the transmission
of infection in the current epidemic. The changes in
R0, the probability of a major epidemic, and ymax are
minimal with changes of ω, in the time scale investi-
gated in this model. However, it must be pointed out
that a long period of immunity will be beneficial in
protecting against future epidemics.
The latent period (1/σ) is important in influencing
the disease dynamics pattern, which indicates that if
the infectious organism takes more time to express its
infectivity, this is advantageous in terms of disease
control. The result reflects the fact that infective organ-
isms with long latent periods are generally of lesser
immediate concern, even if they have a moderate trans-
mission coefficient. It is suggested that genetically in-
creasing the latent period would also be a valid means
of limiting future transmission of infection. A potential
example is scrapie in sheep, where PrP alleles influence
apparent host susceptibility. However, it is often ar-
gued using data from mice (Manson et al., 2000) and
sheep (Gonzalez et al., 2002) that PrP alleles influence
the incubation period (i.e., latency) rather than resis-
tance to infection per se, and this argument is some-
times used to caution against selection on PrP genotype
to limit the spread of infection. The results presented
in this paper suggest that if it were not possible to alter
transmission coefficient, then genetically increasing
the latent period would also help in controlling future
transmission of infection.
The recovery period (1/γ) is also important, as de-
scribed above. It has been observed that a short recov-
ery period can reduce the incidence of a major epidemic
considerably. For instance, in the range of β from0.0001
to 0.001, decreasing the recovery period from 20 to 10
d reduces the chance of major epidemic by approxi-
mately 10 to 50%. Hence, the QTL that decrease recov-
ery period are also valuable for disease control.
The above conclusions have been drawn through a
consideration of epidemic probabilities. However,
broadly equivalent conclusions would also be drawn
by considering the impact on other output parameters,
such as the R0 and ymax values. Decreasing the recovery
period and increasing the latent period could decrease
R0 and ymax considerably and thus help in decreasing
the incidence and severity of major epidemics. Simi-
larly, increased disease-dependent culling would also
decrease R0 and ymax.
The present paper considers the utilization of the
candidate genes or QTL to reduce the transmission of
infection and hence the future incidence of disease.
However, transmission of infection may not be the only
factor determining the importance of a disease or the
success of a control strategy. In practical situations,
the application of a genetic strategy must be viewed in
light of overall economic impact because disease man-
agement is one component of the overall production
system. For example, in addition to the numbers of
animals affected during an epidemic, the impact of in-
fection in terms of the severity of illness, morbidity
and the associated production loss will also affect the
economics. The present model does not consider these
factors or their economic consequences; however, the
model could be used to provide inputs required for a
detailed economic appraisal. This model potentially
gives extensive information on the proportion of indi-
viduals expected to be exposed, to be infected, to re-
cover, or to die during the epidemic and how these may
be affected as a result of a disease control strategy. The
next step may be to relate the time and state of the
disease condition to the appropriate production param-
eters and analyze the economic impact. In other words,
the information presented by our model could provide
much of the necessary input into a full economic evalua-
tion of various control strategies.
To summarize, apart from β, the parameters that
should be of prime importance in designing genetic
strategies for the development of disease-resistant
stocks are σ and γ, and a decision-tree for evaluating
these three parameters is shown in Figure 4. If we
ignore disease-dependent culling in the context of ge-
netic selection, then it is clear from the present study
that both σ and γ are important from an epidemiological
point of view. However, it is difficult to give precedence
of one parameter over another. Rather, it seems that
it would be more practical to consider each disease on
a case-by-case basis in the light of available population
information, epidemiological parameters, and genetic
control strategies. For example, a number of QTL have
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Figure 4. A decision-tree for utilizing quantitative trait loci (QTL) that influence the transmission of infection, the
latent period, and the recovery rate.
been detected for Marek’s disease resistance in poultry
(Vallejo et al., 1998; Yonash et al., 1999). A challenge
exists to critically evaluate the epidemiological implica-
tions of each of these QTL and determine which will
have the greatest impact in helping to control the
disease.
Implications
This paper identifies critical parameters controlling
the transmission of microparasitic infections in domes-
tic livestock using stochastic epidemic models. Critical
parameters are the transmission coefficient, a function
of both the host resistance to infection and the infecti-
vity of infectious animals; the latent period; and the
recovery period. Increasing resistance or the latent pe-
riod, or decreasing the recovery period or the infectivity
of infected animals, will all decrease the incidence of
disease. These results are relevant to the development
of strains of animals with enhanced resistance to spe-
cific infectious diseases. The utility of particular disease
resistance quantitative trait loci or genes to control the
transmission of infection can be determined by equating
measured traits to model parameters and investigating
their predicted impact on the dynamics of potential epi-
demics.
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